Performant Healthcare, Inc.

Greetings and welcome to the Performant Financial Corp second quarter 2022 earnings call. At this time all participants are in a listen only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star and then zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to hand the conference over to your host, Richard Zubik, Investor Relations. Please go ahead.

Thank you, Operator. Good afternoon, everyone. By now, you should have received a copy of the earnings release for the company's second quarter 2022 results. If you have not, a copy is available on the Investor Relations portion of our website. On today's call will be Lisa M., Chief Executive Officer, Damian Cole, President, and Rohit Ramchandani, Senior Vice President of Finance and Strategy. Before we begin, I'd like to remind you that some of the comments made on today's call, including our financial guidance, are forward-looking statements. These statements are subject to risks and uncertainties, including those described in the company's filings with the SEC. Actual results may differ materially from those described during the call. In addition, all forward-looking statements are made as of today and the company does not undertake to update any forward-looking statements based on new circumstances or revised expectations. Also, all non-GAAP financial measures discussed during this call are reconciled to the most directly comparable gap measures in the table attached to our press release. I would now like to turn the call over to Lisa M. Lisa?

Thank you, Rich. Good afternoon, everyone, and thank you for joining us for our earnings call. Our results in the second quarter were right where we thought they would be. Our enhanced efficiencies related to our technology platform combined with our team's continued progress on expanding our commercial operations has us well positioned for continued growth throughout 2022 and beyond. The winter COVID surge related to Omicron largely played out as anticipated in terms of flowed out impact to our results, as the rebound in non-COVID hospital utilization rates remained sluggish during the second quarter. We aren't anticipating anything to suggest that we are racing to return to historical core utilization levels at this time. However, We aren't overly concerned with this as one of the early trends that we have noticed is a shift to rising outpatient services. In some cases, outpatient services have eclipsed inpatient services. It is too early to tell, but this could be the new norm in the post-COVID world. While we anticipate COVID will continue to remain with us for the foreseeable future, At this time, we do not believe we will see a precipitous drop in core utilization rates this year as we did last year. Overall, we are pleased with the pace of our transition and our ability to continue to gain market share, which would not be possible without our incredible, hardworking team members. Thank you again for your dedication and commitment to performance. With that, I'll turn things over to Simeon Coles, to discuss the second quarter and other initiatives in greater detail. Tim?